Difference between revisions of "Team:CKWA-China"
Dragon210331 (Talk | contribs) |
Dragon210331 (Talk | contribs) |
||
| Line 254: | Line 254: | ||
controls="“ture”"></video> | controls="“ture”"></video> | ||
</div> | </div> | ||
| − | <div class="content-box"> | + | <div class="content-box" style="text-align:center;"> |
<h3>Here's the subject of the video</h3> | <h3>Here's the subject of the video</h3> | ||
<div class="text">I could write some video notes here, a little bit more introduction. | <div class="text">I could write some video notes here, a little bit more introduction. | ||
Revision as of 05:04, 19 October 2021
-
We Proudly Service
These Metro Markets
Flooring is a family-owned and operated business. we have been installing floorssince 1992 and have installed flooring and Tilling -
We Proudly Service
These Metro Markets
Flooring is a family-owned and operated business. we have been installing floorssince 1992 and have installed flooring and Tilling -
We Proudly Service
These Metro Markets
Flooring is a family-owned and operated business. we have been installing floorssince 1992 and have installed flooring and Tilling -
We Proudly Service
These Metro Markets
Flooring is a family-owned and operated business. we have been installing floorssince 1992 and have installed flooring and Tilling
LonEase
Recurrence of cancer after surgical treatment is a major problem facing mankind nowadays, and cancer recurrence is a great threat for cancer patients. For example, bladder cancer recurs in up to 24%-84% of patients 5 years after surgical resection, in which overexpression of C-MYC protein is associated with approximately 44%-69% of these cases. We have investigated that Lon protein from uropathogenic Escherichia coli (UPEC) can be effective enough to degrade C-MYC protein and thus inhibit the proliferation of cancer cells. We plan to produce highly active Lon protease from E. coli this year and use it to design a drug to improve the surgical prognosis of bladder cancer population with C-myc gene overexpression.